Myasthenia gravis: open trials in Switzerland

• NCT07217587

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen

  Registry updated 2026-11-03

• NCT06463587

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  Inselspital - Universitaetsspital Bern - Neuropsychologische Rehabilitation, Neurologie, Bern

  Registry updated 2026-10-21

• NCT06392386

  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Hôpital Nestlé, Lausanne

  Registry updated 2026-09-28

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error